drugset / Trial / NCT00056082
Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
Phase 2
Completed
110 enrolled
University of Kansas Medical Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelPrevention
Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or recurrence of cancer. Celecoxib may be effective in preventing breast cancer in at-risk women. PURPOSE: Phase II trial to study the effectiveness of celecoxib in preventing breast cancer in premenopausal women who are at risk of developing cancer.
Timeline
- Start
- 2003-01
- Primary completion
- 2008-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |